Growth Metrics

Eton Pharmaceuticals (ETON) Long-Term Debt Repayments (2022 - 2024)

Historic Long-Term Debt Repayments for Eton Pharmaceuticals (ETON) over the last 3 years, with Q3 2024 value amounting to $385000.0.

  • Eton Pharmaceuticals' Long-Term Debt Repayments changed 0.0% to $385000.0 in Q3 2024 from the same period last year, while for Jun 2025 it was $385000.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $1.2 million for FY2024, which is 0.0% changed from last year.
  • Per Eton Pharmaceuticals' latest filing, its Long-Term Debt Repayments stood at $385000.0 for Q3 2024, which was down 0.0% from $385000.0 recorded in Q2 2024.
  • Eton Pharmaceuticals' 5-year Long-Term Debt Repayments high stood at $385000.0 for Q1 2022, and its period low was $385000.0 during Q1 2022.
  • In the last 3 years, Eton Pharmaceuticals' Long-Term Debt Repayments had a median value of $385000.0 in 2022 and averaged $385000.0.
  • The largest annual percentage gain for Eton Pharmaceuticals' Long-Term Debt Repayments in the last 5 years was 0.0% (2024), contrasted with its biggest fall of 0.0% (2024).
  • Quarter analysis of 3 years shows Eton Pharmaceuticals' Long-Term Debt Repayments stood at $385000.0 in 2022, then changed by 0.0% to $385000.0 in 2023, then changed by 0.0% to $385000.0 in 2024.
  • Its Long-Term Debt Repayments was $385000.0 in Q3 2024, compared to $385000.0 in Q2 2024 and $385000.0 in Q1 2024.